850311P-100MG Display Image

DOCP

Code: 850311P-100MG D2-231

Application

DOCP is suitable for use in preparation ofsupported phospholipid monolayer for human C-reactive protein binding studieslarge unilamellar vesicles (LUVs)liposomes ...


read more

Your Price
£461.00 100MG

Application

DOCP is suitable for use in preparation ofsupported phospholipid monolayer for human C-reactive protein binding studieslarge unilamellar vesicles (LUVs)liposomes for uptake studies in human astrocytes

General description

Inverse-phosphocholine lipids, a remix of a common phospholipid, contain headgroups with an inverted charge orientation relative to phosphocholine (PC) lipids. The iPC lipid headgroup has a quaternary amine adjacent to the bilayer interface and a phosphate that extends into the aqueous phase. Therefore iPC lipids afford a unique opportunity to investigate the biophysical and bioactivity-related ramifications of a charge inversion at the bilayer surface.

Packaging

20 mL Clear Glass Screw Cap Vial (850311P-200mg)

5 mL Amber Glass Screw Cap Vial (850311P-100mg)

assay>99% (TLC)
formpowder
manufacturer/tradenameAvanti Polar Lipids 850311P
packagingpkg of 1 × 100 mg (850311P-100mg), pkg of 1 × 200 mg (850311P-200mg)
shipped indry ice
SMILES string[H]C(C[N+](C)(CCOP([O-])(O)=O)C)(OC(CCCCCCC/C=CCCCCCCCC)=O)COC(CCCCCCC/C=CCCCCCCCC)=O
storage temp.−20°C
Cas Number1360461-57-9
This product has met the following criteria: